S L Suryawanshi1, H D Shewade2, S B Nagaraja3, S A Nair1, M Parmar1. 1. World Health Organization, Country Office for India, New Delhi, India. 2. International Union Against Tuberculosis and Lung Disease, South-East Asia Office, New Delhi, India. 3. Department of Community Medicine, Employees' State Insurance Corporation Medical College and Post Graduate Institute of Medical Sciences and Research, Bangalore, India.
Abstract
Setting: Patients with multidrug-resistant tuberculosis (MDR-TB) registered for treatment (2011-2012 cohort) using the standard 24-month regimen, under the Revised National TB Control Programme's programmatic management of drug-resistant TB (PMDT), Maharashtra, India. Objectives: To assess the treatment outcomes and the timing and risk factors for unfavourable treatment outcomes, with a focus on death and loss to follow-up (LTFU). Method: This was a retrospective cohort study involving a review of PMDT records. Treatment outcomes were reported on 31 December 2014. Results: Of 4024 patients, treatment success was recorded in 1168 (29%). Unfavourable outcomes occurred in 2242 (56%), of whom 857 (21%) died and 768 (19%) were lost to follow-up. Treatment outcomes were missing on record review for 375 (9%) patients, and 239 (6%) were still undergoing treatment. Half of LTFU occurred within 3 months, and more than four fifths of deaths occurred after 6 months of treatment. Human immunodeficiency virus infection, being underweight, age ⩾ 15 years, male sex and pulmonary TB were the main risk factors for death, LTFU or other unfavourable treatment outcomes. Conclusion: The study found poor treatment outcomes in patients with MDR-TB registered for treatment in Maharashtra, India. Interventions are required to address the high rates of LTFU and death.
Setting: Patients with multidrug-resistant tuberculosis (MDR-TB) registered for treatment (2011-2012 cohort) using the standard 24-month regimen, under the Revised National TB Control Programme's programmatic management of drug-resistant TB (PMDT), Maharashtra, India. Objectives: To assess the treatment outcomes and the timing and risk factors for unfavourable treatment outcomes, with a focus on death and loss to follow-up (LTFU). Method: This was a retrospective cohort study involving a review of PMDT records. Treatment outcomes were reported on 31 December 2014. Results: Of 4024 patients, treatment success was recorded in 1168 (29%). Unfavourable outcomes occurred in 2242 (56%), of whom 857 (21%) died and 768 (19%) were lost to follow-up. Treatment outcomes were missing on record review for 375 (9%) patients, and 239 (6%) were still undergoing treatment. Half of LTFU occurred within 3 months, and more than four fifths of deaths occurred after 6 months of treatment. Human immunodeficiency virus infection, being underweight, age ⩾ 15 years, male sex and pulmonary TB were the main risk factors for death, LTFU or other unfavourable treatment outcomes. Conclusion: The study found poor treatment outcomes in patients with MDR-TB registered for treatment in Maharashtra, India. Interventions are required to address the high rates of LTFU and death.
Entities:
Keywords:
India; death; loss to follow-up; multidrug-resistant tuberculosis; operational research
Authors: Armand Van Deun; Aung Kya Jai Maug; Md Abdul Hamid Salim; Pankaj Kumar Das; Mihir Ranjan Sarker; Paul Daru; Hans L Rieder Journal: Am J Respir Crit Care Med Date: 2010-05-04 Impact factor: 21.405
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: Lancet Date: 2007-10-20 Impact factor: 79.321
Authors: Dina Nair; Pooranaganga D Navneethapandian; Jaya Prasad Tripathy; Anthony D Harries; Joel S Klinton; Basilea Watson; Gomathi N Sivaramakrishnan; Devarajulu S Reddy; Lakshmi Murali; Mohan Natrajan; Soumya Swaminathan Journal: Trans R Soc Trop Med Hyg Date: 2016-10-13 Impact factor: 2.184
Authors: R M Hicks; N Padayatchi; N S Shah; A Wolf; L Werner; V B Sunkari; M R O'Donnell Journal: Int J Tuberc Lung Dis Date: 2014-09 Impact factor: 2.373
Authors: A Piubello; S Hassane Harouna; M B Souleymane; I Boukary; S Morou; M Daouda; Y Hanki; A Van Deun Journal: Int J Tuberc Lung Dis Date: 2014-10 Impact factor: 2.373
Authors: Karuna D Sagili; Srinath Satyanarayana; Sarabjit S Chadha; Nevin C Wilson; Ajay M V Kumar; Patrick K Moonan; John E Oeltmann; Vineet K Chadha; Sharath Burugina Nagaraja; Smita Ghosh; Terrence Q Lo; Tyson Volkmann; Matthew Willis; Kalpita Shringarpure; Ravichandra Chinnappa Reddy; Prahlad Kumar; Sreenivas A Nair; Raghuram Rao; Mohammed Yassin; Perry Mwangala; Rony Zachariah; Jamhoih Tonsing; Anthony D Harries; Sunil Khaparde Journal: Glob Health Action Date: 2018 Impact factor: 2.640